News & Wissen

13 10 22

VPP Vortragsveranstaltung der Bezirksgruppe Mitte-Süd

02 08 22

Nachhaltigkeitspreis für die Patentanwaltskanzlei Isenbruck Bösl Hörschler

01 01 22

We are pleased to announce that Dr. Ivo Ruttekolk has become a Salary Partner of our firm as of January 1, 2022.

28 10 21

EPO's Enlarged Board of Appeal publishes reasoning in case G 1/21 regarding video conferencing

09 07 21

Federal Constitutional Court clears way for Ratification of Unified Patent Court

02 07 21

IAM Patent 1000 recommends Isenbruck Bösl Hörschler

17 06 21

Isenbruck Bösl Hörschler again ranked among "Europe's Leading Patent Law Firms 2021" by the Financial Times

23 04 21

Surprising effects and inventive step in the jurisdictions of Germany, the US, Europe and Japan

Dr. Stefan Féaux de Lacroix

30 12 20

Patenting Polymers in EP – A Practical Advice

Dr. Dorothee Hollah

18 12 20

EPO Closure Period extended

10 12 20

BREXIT – Informationen zu Ihren IP-Rechten

26 09 20

Federal Court of Justice invalidates SPC for Gilead blockbuster drug Truvada

25 09 20

Amicus Curie Brief regarding G 4/19

Dr. Stefan Féaux de Lacroix

15 09 20

We are pleased to announce that the article “Disclaimer – und kein Ende?” by our Partner Dr. Stefan Féaux de Lacroix has been published in Mitteilungen der deutschen Patentanwälte, No. 9.

18 06 20

Isenbruck Bösl Hörschler ranked among "Europe's Leading Patent Law Firms 2020" by the Financial Times

14 05 20

Decision G 03/19 of the Enlarged Board of Appeal – Dynamic interpretation of Article 53(b) EPC in view of the alteration of Rule 28 EPC

Dr. Ivo Ruttekolk

01 05 20

Erneute Fristverlängerung des EPA auf den 2. Juni 2020

29 04 20

EUIPO – Erneute Verlängerung der Fristen bis zum 18. Mai 2020

16 04 20

EPA verlängert Fristen erneut

09 04 20

DPMA verlängert Fristen

23 03 20

Update on UPC

16 03 20

EUIPO – Verlängerung der aktuellen Fristen bis zum 1. Mai 2020

15 03 20

EPA verlängert Fristen

01 02 20

AFTER BREXIT – Information regarding your IP rights

22 01 20

Save the Date - Afternoon Seminar Followed by Reception on March 12, 2020

18 07 19

Die Patentanwälte Isenbruck Bösl Hörschler PartG mbB unterstützen am 18. Juli 2019 die Handwerkskammer Rhein-Neckar-Odenwald beim Erfindersprechtag

12 04 19

IP Seminar in Kooperation mit BioRN Network e.V. am 21. Mai 2019

27 02 19

When case law overrules legal norms – Are classical plant patents back? T 1063/18 (Extreme dark green, blocky peppers / SYNGENTA)

Dr. Ivo Ruttekolk

01 01 19

Angesichts des bevorstehenden BREXITs sind wir seit 2019 in neuer Rechtsform als Partnerschaftsgesellschaft mit beschränkter Berufshaftung (PartG mbB) für Sie tätig.

18 10 18

The “Druckexemplar” determines the extent of protection conferred by a European patent

Dr. Raphael Bösl

17 08 18

Restoration of the Right of Priority under the PCT – different “Criterion for Restoration” before the USPTO and the EPO

Dr. Raphael Bösl

09 05 18

License Fees for a Compulsory License – Isentress II – German Federal Patent Court

Dr. Raphael Bösl

31 08 17

Follow-up: Preliminary Injunction confirmed by the German Federal Supreme Court in a Compulsory License Proceedings concerning a Medicament against AIDS

Dr. Raphael Bösl

12 07 17

Preliminary Injunction confirmed by the German Federal Supreme Court in a Compulsory License Proceedings concerning a Medicament against AIDS

Dr. Raphael Bösl

04 07 17

EPO clarifies practice in the area of plant and animal patents

Dr. Raphael Bösl

13 02 17

Urgent Notice of the Federal Patent Court: Preliminary Injunction issued in a Compulsory License Proceedings concerning “Isentress” (raltegravir against AIDS)

Dr. Raphael Bösl

22 12 16

EPO stays all proceedings in which the invention is a plant or animal obtained by an essentially biological process

Dr. Raphael Bösl

01 09 16

A brief summary of the revision of § 34a of the German Patent Law regarding the requirements for the use of genetic resources was published in BIO Deutschland Rechtsinfo aktuell August 2016.

Dr. Ivo Ruttekolk

27 07 16

Communication from the Chairmen of the UPC Preparatory Committee and the EPO Select Committee dealing with the Unitary Patent of July 1, 2016

Dr. Raphael Bösl

17 02 16

Functional Features – Essential Features: A New Perspective under Article 84 EPC

Dr. Raphael Bösl

26 10 15

An article summarizing the possible impact of the implementation of the Nagoya-Protocol and the EU regulation No. 511/2014 on patent practice in the biotech sector by Ivo Ruttekolk was published

Dr. Ivo Ruttekolk

11 09 15

Plant Patent Protection and Plant Variety Protection – Two Independent IP Rights?

Dr. Raphael Bösl

21 08 15

A pitfall to supplement information incorporated by reference under the EPC

Dr. Raphael Bösl

30 06 15

EPO: claims directed to the use of a product produced by a process

Dr. Raphael Bösl

27 03 15

Enlarged Board of Appeal of the EPO decided on Clarity – expected decision now issued (G 3/14)

Dr. Raphael Bösl

26 01 15

The article “EPA T 1247/12 – Insektizid-Ausrüstung von Textilien” by Markus Jacobi was published in IP kompakt

Dr. Markus Jacobi

07 11 14

Deautomation is not per se Inventive – an Exemption from the Rule under the EPC

Dr. Raphael Bösl

12 09 14

Four Step Approach in Determining Sufficiency of Disclosure of a Parameter under the EPC

Dr. Raphael Bösl

04 07 14

Refocus on the Interpretation of “Undue Burden” for the Determination of the Scope of Protection under the EPC

Dr. Raphael Bösl

10 01 14

Functional Definition of Compounds in Use Claims – Different Decisions in Germany and “Europe”

Dr. Raphael Bösl

Autoren

Sprache

Alle Beiträge

VPP Vortragsveranstaltung der Bezirksgruppe Mitte-Süd

Nachhaltigkeitspreis für die Patentanwaltskanzlei Isenbruck Bösl Hörschler

We are pleased to announce that Dr. Ivo Ruttekolk has become a Salary Partner of our firm as of January 1, 2022.

EPO's Enlarged Board of Appeal publishes reasoning in case G 1/21 regarding video conferencing

Federal Constitutional Court clears way for Ratification of Unified Patent Court

IAM Patent 1000 recommends Isenbruck Bösl Hörschler

Isenbruck Bösl Hörschler again ranked among "Europe's Leading Patent Law Firms 2021" by the Financial Times

Surprising effects and inventive step in the jurisdictions of Germany, the US, Europe and Japan

Patenting Polymers in EP – A Practical Advice

EPO Closure Period extended

BREXIT – Informationen zu Ihren IP-Rechten

Federal Court of Justice invalidates SPC for Gilead blockbuster drug Truvada

Amicus Curie Brief regarding G 4/19

We are pleased to announce that the article “Disclaimer – und kein Ende?” by our Partner Dr. Stefan Féaux de Lacroix has been published in Mitteilungen der deutschen Patentanwälte, No. 9.

Isenbruck Bösl Hörschler ranked among "Europe's Leading Patent Law Firms 2020" by the Financial Times

Decision G 03/19 of the Enlarged Board of Appeal – Dynamic interpretation of Article 53(b) EPC in view of the alteration of Rule 28 EPC

Erneute Fristverlängerung des EPA auf den 2. Juni 2020

EUIPO – Erneute Verlängerung der Fristen bis zum 18. Mai 2020

EPA verlängert Fristen erneut

DPMA verlängert Fristen

Update on UPC

EUIPO – Verlängerung der aktuellen Fristen bis zum 1. Mai 2020

EPA verlängert Fristen

AFTER BREXIT – Information regarding your IP rights

Save the Date - Afternoon Seminar Followed by Reception on March 12, 2020

Die Patentanwälte Isenbruck Bösl Hörschler PartG mbB unterstützen am 18. Juli 2019 die Hand­werks­kammer Rhein-Neckar-Odenwald beim Erfindersprechtag

IP Seminar in Kooperation mit BioRN Network e.V. am 21. Mai 2019

When case law overrules legal norms – Are classical plant patents back? T 1063/18 (Extreme dark green, blocky peppers / SYNGENTA)

Angesichts des bevorstehenden BREXITs sind wir seit 2019 in neuer Rechtsform als Partner­schafts­gesellschaft mit beschränkter Berufs­haftung (PartG mbB) für Sie tätig.

The “Druckexemplar” determines the extent of protection conferred by a European patent

Restoration of the Right of Priority under the PCT – different “Criterion for Restoration” before the USPTO and the EPO

License Fees for a Compulsory License – Isentress II – German Federal Patent Court

Follow-up: Preliminary Injunction confirmed by the German Federal Supreme Court in a Compulsory License Proceedings concerning a Medicament against AIDS

Preliminary Injunction confirmed by the German Federal Supreme Court in a Compulsory License Proceedings concerning a Medicament against AIDS

EPO clarifies practice in the area of plant and animal patents

Urgent Notice of the Federal Patent Court: Preliminary Injunction issued in a Compulsory License Proceedings concerning “Isentress” (raltegravir against AIDS)

EPO stays all proceedings in which the invention is a plant or animal obtained by an essentially biological process

A brief summary of the revision of § 34a of the German Patent Law regarding the requirements for the use of genetic resources was published in BIO Deutschland Rechtsinfo aktuell August 2016.

Communication from the Chairmen of the UPC Preparatory Committee and the EPO Select Committee dealing with the Unitary Patent of July 1, 2016

Functional Features – Essential Features: A New Perspective under Article 84 EPC

An article summarizing the possible impact of the implementation of the Nagoya-Protocol and the EU regulation No. 511/2014 on patent practice in the biotech sector by Ivo Ruttekolk was published

Plant Patent Protection and Plant Variety Protection – Two Independent IP Rights?

A pitfall to supplement information incorporated by reference under the EPC

EPO: claims directed to the use of a product produced by a process

Enlarged Board of Appeal of the EPO decided on Clarity – expected decision now issued (G 3/14)

The article “EPA T 1247/12 – Insektizid-Ausrüstung von Textilien” by Markus Jacobi was published in IP kompakt

Deautomation is not per se Inventive – an Exemption from the Rule under the EPC

Four Step Approach in Determining Sufficiency of Disclosure of a Parameter under the EPC

Refocus on the Interpretation of “Undue Burden” for the Determination of the Scope of Protection under the EPC

Functional Definition of Compounds in Use Claims – Different Decisions in Germany and “Europe”

Die Patentanwälte Isenbruck Bösl Hörschler PartG mbB unterstützen am 18. Juli 2019 die Handwerkskammer Rhein-Neckar-Odenwald beim Erfindersprechtag

Angesichts des bevorstehenden BREXITs sind wir seit 2019 in neuer Rechtsform als Partnerschaftsgesellschaft mit beschränkter Berufshaftung (PartG mbB) für Sie tätig.